BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
40 results:

  • 1. Global and promoter specific hypermethylation of tumor suppressor genes P16, socs1, and SHP1 in oral squamous cell carcinoma and oral submucous fibrosis.
    Ukey S; Jain A; Dwivedi S; Vishnoi JR; Chugh A; Purohit P; Pareek P; Elhence P; Misra S; Sharma P
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S551-S559. PubMed ID: 38384018
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. socs1 Gene Therapy for head and neck cancers: An Experimental Study.
    Kajiyama T; Serada S; Fujimoto M; Ohkawara T; Komori M; Hyodo M; Naka T
    Anticancer Res; 2022 Jul; 42(7):3361-3372. PubMed ID: 35790291
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mast cell marker gene signature in head and neck squamous cell carcinoma.
    Cai Z; Tang B; Chen L; Lei W
    BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gene therapy with socs1 induces potent preclinical antitumor activities in oral squamous cell carcinoma.
    Nakatani K; Serada S; Fujimoto M; Obata K; Ohkawara T; Sasabe E; Yamamoto T; Naka T
    J Oral Pathol Med; 2022 Feb; 51(2):126-133. PubMed ID: 34878693
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A Novel Ferroptosis-Related Gene Signature to Predict Prognosis in Patients with head and neck Squamous Cell Carcinoma.
    Xu L; Li YY; Zhang YC; Wu YX; Guo DD; Long D; Liu ZH
    Dis Markers; 2021; 2021():5759927. PubMed ID: 34853622
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive analysis of ubiquitin-proteasome system genes related to prognosis and immunosuppression in head and neck squamous cell carcinoma.
    Wang J; Li J; Zhang L; Qin Y; Zhang F; Hu R; Chen H; Tian Y; Liu Z; Tian Y; Zhang X
    Aging (Albany NY); 2021 Aug; 13(16):20277-20301. PubMed ID: 34398824
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. GFI1 promotes the proliferation and migration of esophageal squamous cell carcinoma cells through the inhibition of socs1 expression.
    Huang Y; Ruan R; Fang Y; Wu K; Yao L; Zhang R; He W
    Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368875
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis.
    Yang W; Zhou W; Zhao X; Wang X; Duan L; Li Y; Niu L; Chen J; Zhang Y; Han Y; Fan D; Hong L
    Hereditas; 2021 Apr; 158(1):15. PubMed ID: 33892811
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Bone marrow mesenchymal stem cells-derived exosomal microRNA-19b-3p targets socs1 to facilitate progression of esophageal cancer.
    Deng Y; Julaiti A; Ran W; He Y
    Life Sci; 2021 Aug; 278():119491. PubMed ID: 33862112
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. LINC00669 insulates the JAK/STAT suppressor socs1 to promote nasopharyngeal cancer cell proliferation and invasion.
    Qing X; Tan GL; Liu HW; Li W; Ai JG; Xiong SS; Yang MQ; Wang TS
    J Exp Clin Cancer Res; 2020 Aug; 39(1):166. PubMed ID: 32831137
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells.
    Bian LH; Duan JL; Zhou C; Shen GW; Wang XY; Yang Y; Zhang XL; Xiao SJ
    Mol Med Rep; 2020 Jul; 22(1):51-56. PubMed ID: 32377721
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tripartite motif containing 14: An oncogene in papillary thyroid carcinoma.
    Sun W; Wang Y; Li D; Wu Y; Ji Q; Sun T
    Biochem Biophys Res Commun; 2020 Jan; 521(2):360-367. PubMed ID: 31668806
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Suppressor of cytokine signaling 1 (socs1) silencing and Hep-2 sensitizing dendritic cell vaccine in laryngocarcinoma immunotherapy.
    Yuan Y; Li GY; Ji M; Zhang Y; Ding YP; Qi XC
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5958-5966. PubMed ID: 31298347
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. STING signaling remodels the tumor microenvironment by antagonizing myeloid-derived suppressor cell expansion.
    Zhang CX; Ye SB; Ni JJ; Cai TT; Liu YN; Huang DJ; Mai HQ; Chen QY; He J; Zhang XS; Zeng YX; Li J; Cui J
    Cell Death Differ; 2019 Nov; 26(11):2314-2328. PubMed ID: 30816302
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Oral squamous cell carcinoma-derived exosomes promote M2 subtype macrophage polarization mediated by exosome-enclosed miR-29a-3p.
    Cai J; Qiao B; Gao N; Lin N; He W
    Am J Physiol Cell Physiol; 2019 May; 316(5):C731-C740. PubMed ID: 30811223
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effects of epidermal growth factor receptor fusion protein on the cytotoxic activity of socs1-silenced dendritic cells in vitro.
    Jiang Q; Wang X; Qian M; Chen D; Xu Y
    Oncol Rep; 2018 Mar; 39(3):1306-1312. PubMed ID: 29286121
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. socs1 Gene Therapy Improves Radiosensitivity and Enhances Irradiation-Induced DNA Damage in Esophageal Squamous Cell Carcinoma.
    Sugase T; Takahashi T; Serada S; Fujimoto M; Hiramatsu K; Ohkawara T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Kishimoto T; Mori M; Doki Y; Naka T
    Cancer Res; 2017 Dec; 77(24):6975-6986. PubMed ID: 29042418
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Significance of expression of suppressor of cytokine signaling proteins: Suppressor of cytokine signaling-1, suppressor of cytokine signaling-2, and suppressor of cytokine signaling-3 in papillary thyroid cancer.
    Kobawala TP; Trivedi TI; Gajjar KK; Patel GH; Ghosh NR
    J Cancer Res Ther; 2017; 13(2):337-345. PubMed ID: 28643757
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.
    Sugase T; Takahashi T; Serada S; Nakatsuka R; Fujimoto M; Ohkawara T; Hara H; Nishigaki T; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Kishimoto T; Mori M; Doki Y; Naka T
    Int J Cancer; 2017 Jun; 140(11):2608-2621. PubMed ID: 28233302
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.